Daniel Rauh

13.3k total citations · 1 hit paper
156 papers, 7.3k citations indexed

About

Daniel Rauh is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Daniel Rauh has authored 156 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 54 papers in Organic Chemistry and 35 papers in Oncology. Recurrent topics in Daniel Rauh's work include Melanoma and MAPK Pathways (27 papers), Lung Cancer Treatments and Mutations (25 papers) and HER2/EGFR in Cancer Research (22 papers). Daniel Rauh is often cited by papers focused on Melanoma and MAPK Pathways (27 papers), Lung Cancer Treatments and Mutations (25 papers) and HER2/EGFR in Cancer Research (22 papers). Daniel Rauh collaborates with scholars based in Germany, United States and South Africa. Daniel Rauh's co-authors include Herbert Waldmann, Christian Grütter, Vladimir Dyakonov, Carsten Deibel, Jeffrey R. Simard, Andrey P. Antonchick, Viktor V. Vintonyak, Matthias Rabiller, Stefan Wetzel and Matthäus Getlik and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Daniel Rauh

153 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Highly enantioselective synthesis and cellular evaluation of spirooxindoles inspired by natural products

2010 519 citations Daniel Rauh, Herbert Waldmann et al. Nature Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Rauh Germany	47	3.8k	2.5k	1.2k	841	785	156	7.3k
Shengyong Yang China	46	5.6k 1.5×	2.4k 0.9×	1.4k 1.1×	1.6k 1.9×	134 0.2×	258	10.0k
Chao‐Yie Yang United States	42	5.7k 1.5×	1.0k 0.4×	1.9k 1.5×	1.1k 1.4×	114 0.1×	105	7.1k
Danuta S. Kalinowski Australia	51	3.4k 0.9×	2.3k 0.9×	3.5k 2.9×	242 0.3×	98 0.1×	113	8.7k
Gang Cheng China	36	2.4k 0.6×	872 0.3×	1.3k 1.1×	89 0.1×	294 0.4×	185	6.5k
David J. Maloney United States	43	3.3k 0.9×	991 0.4×	905 0.7×	363 0.4×	99 0.1×	140	5.6k
Laurence H. Hurley United States	81	21.5k 5.7×	3.6k 1.4×	2.0k 1.6×	179 0.2×	460 0.6×	259	24.1k
Malcolm F. G. Stevens United Kingdom	48	4.1k 1.1×	4.1k 1.6×	849 0.7×	306 0.4×	80 0.1×	203	8.7k
Thomas Schräder Germany	46	3.2k 0.8×	2.0k 0.8×	254 0.2×	258 0.3×	170 0.2×	213	6.4k
Per Hammarström Sweden	45	4.5k 1.2×	381 0.1×	361 0.3×	450 0.5×	216 0.3×	145	7.2k
He Huang China	44	3.7k 1.0×	1.2k 0.5×	533 0.4×	53 0.1×	765 1.0×	143	6.6k

Countries citing papers authored by Daniel Rauh

Since Specialization

Citations

This map shows the geographic impact of Daniel Rauh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rauh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rauh more than expected).

Fields of papers citing papers by Daniel Rauh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Rauh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rauh. The network helps show where Daniel Rauh may publish in the future.

Co-authorship network of co-authors of Daniel Rauh

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Rauh. A scholar is included among the top collaborators of Daniel Rauh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Rauh. Daniel Rauh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Falkenhorst, Johanna, Philipp Ivanyi, Rainer Hamacher, et al.. (2025). Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial). Clinical Cancer Research. 31(19). 4059–4069.

Gontla, Rajesh, Thomas Mühlenberg, Jörn Weisner, et al.. (2024). Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA. Nature Communications. 15(1). 63–63. 16 indexed citations

Ehrt, Christiane, Wolf Hiller, Carina Seitz, et al.. (2023). Fragtory: Pharmacophore-Focused Design, Synthesis, and Evaluation of an sp³-Enriched Fragment Library. Journal of Medicinal Chemistry. 66(9). 6297–6314. 5 indexed citations

Goebel, Lisa, Petra Janning, Stefano Maffini, et al.. (2023). Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. eLife. 12. 3 indexed citations

Beck, Michael E., et al.. (2023). Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible Aminopyrimidines. ACS Medicinal Chemistry Letters. 14(5). 591–598. 11 indexed citations

Weisner, Jörn, et al.. (2023). Insights into the Conformational Plasticity of the Protein Kinase Akt1 by Multi‐Lateral Dipolar Spectroscopy. Chemistry - A European Journal. 29(24). e202203959–e202203959. 4 indexed citations

Müller, Matthias, et al.. (2020). Complex Crystal Structures of EGFR with Third-Generation Kinase Inhibitors and Simultaneously Bound Allosteric Ligands. ACS Medicinal Chemistry Letters. 11(12). 2484–2490. 31 indexed citations

Lategahn, Jonas, Marina Keul, Hannah L. Tumbrink, et al.. (2020). Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach. Journal of Medicinal Chemistry. 63(20). 11725–11755. 12 indexed citations

Lategahn, Jonas, et al.. (2019). Structure Defines Function: Clinically Relevant Mutations in ErbB Kinases. Journal of Medicinal Chemistry. 63(1). 40–51. 13 indexed citations

10.

Lategahn, Jonas, Harold Hilarion Fokoue, Carlos Maurício R. Sant’Anna, et al.. (2019). A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives. Scientific Reports. 9(1). 14–14. 42 indexed citations

11.

Uhlenbrock, Niklas, Steven P. Smith, Jörn Weisner, et al.. (2019). Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt. Chemical Science. 10(12). 3573–3585. 52 indexed citations

12.

Chatterjee, Sampurna, Lukas C. Heukamp, Jakob Schöttle, et al.. (2013). Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. Journal of Clinical Investigation. 123(4). 1732–1740. 164 indexed citations

13.

Over, Björn, Stefan Wetzel, Christian Grütter, et al.. (2012). Natural-product-derived fragments for fragment-based ligand discovery. Nature Chemistry. 5(1). 21–28. 233 indexed citations

14.

Heuckmann, Johannes M., Michael Hölzel, Martin L. Sos, et al.. (2011). ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors. Clinical Cancer Research. 17(23). 7394–7401. 147 indexed citations

15.

Koeberle, Solveigh C., Andreas Koeberle, Verena Schattel, et al.. (2011). Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor. Nature Chemical Biology. 8(2). 141–143. 106 indexed citations

16.

Sos, Martin L., Haridas B. Rode, Stefanie Heynck, et al.. (2010). Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation. Cancer Research. 70(3). 868–874. 175 indexed citations

17.

Wagenpfahl, Alexander, Daniel Rauh, Michael Binder, Carsten Deibel, & Vladimir Dyakonov. (2010). On the s-shape current-voltage characteristics of organic solar devices. arXiv (Cornell University). 2 indexed citations

18.

Klüter, Sabine, Jeffrey R. Simard, Haridas B. Rode, et al.. (2010). Characterization of Irreversible Kinase Inhibitors by Directly Detecting Covalent Bond Formation: A Tool for Dissecting Kinase Drug Resistance. ChemBioChem. 11(18). 2557–2566. 38 indexed citations

19.

Wetzel, Stefan, Karsten Klein, Steffen Renner, et al.. (2009). Interactive exploration of chemical space with Scaffold Hunter. Nature Chemical Biology. 5(8). 581–583. 169 indexed citations

20.

Rauh, Daniel, G. Klebe, & Milton T. Stubbs. (2003). Understanding Protein–Ligand Interactions: The Price of Protein Flexibility. Journal of Molecular Biology. 335(5). 1325–1341. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact